| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.7M | — | +171.9% |
| Cost of Revenue | $1.2M | — | +255.4% |
| Gross Profit | $1.6M | — | +131.8% |
| R&D Expense | $9.7M | — | -26.2% |
| Operating Income | -$23.4M | — | +38.5% |
| Pre-tax Income | -$22.6M | — | +84.7% |
| Income Tax | $99K | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $33.2M | -27.4% | -26.1% |
| Inventory | $9.0M | -11.0% | +7.5% |
| Current Assets | $65.4M | -32.3% | -30.1% |
| Total Assets | $70.8M | -30.8% | -29.4% |
| Current Liabilities | $26.5M | -38.8% | -31.0% |
| Total Liabilities |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$12.6M | — | +20.8% |
| Capital Expenditures | $116K | — | -82.5% |
| Investing Cash Flow | -$116K | — | +82.5% |
| Financing Cash Flow | $58K | — | -99.5% |
| Free Cash Flow | -$12.7M | — | +23.2% |
| -38.9% |
| Net Income | -$22.7M | — | +84.7% |
| EPS (Basic) | -$0.19 | — | +88.2% |
| EPS (Diluted) | -$0.19 | — | +88.2% |
| $45.3M |
| -28.3% |
| -10.2% |
| Stockholders' Equity | $25.4M | -34.8% | +52.3% |